Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingfang orange peel zhuru granules is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Jilin Provincial Tumor Hospital. It is specifically indicated for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in cancer patients. The name "Jingfang" (经方) indicates that the formulation is based on a "Classical Formula," specifically the *Chenpi Zhuru Tang* (Orange Peel and Bamboo Shavings Decoction) from the ancient medical text *Jingui Yaolue*. The preparation contains *Citrus reticulata* peel (Chenpi) and *Bambusae Caulis in Taeniam* (Zhuru) as its primary active components. From a TCM perspective, the granules work by harmonizing the stomach, regulating qi, and descending adverse qi to alleviate emetic symptoms. It is typically administered orally and serves as a supportive care option to improve the quality of life for patients undergoing cytotoxic chemotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jingfang orange peel zhuru granules.